NCT03701334, A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2− Early Breast Cancer (NATALEE). NIH U.S. National Library of Medicine - clinicaltrials.gov (2018)